Grade of severity of AP | |||||||
Mild (n = 84) | Severe (n = 84) | p-value | |||||
Gender† | |||||||
Males | 56 (66.7%) | 29 (65.9%) | >0.05 | ||||
Females | 28 (33.3%) | 15 (34.1%) | |||||
Age (years) | 49 ± 12 | 50 ± 15 | >0.05 | ||||
Hospital stay (days), mean | 10.2 | 22.6 | <0.001 | ||||
S-amylase (IU/L) | 938 ± 335 | 1088 ± 248 | >0.05 | ||||
APACHE II score† | |||||||
≥9 | 9 (10.7%) | 40 (90.9%) | <0.0001 | ||||
<9 | 75 (89.3%) | 4 (9.1%) | |||||
Ranson score† | |||||||
≥3 | 8 (9.5%) | 40 (90.9%) | <0.0001 | ||||
<3 | 76 (91.5%) | 4 (9.1%) | |||||
Glasgow score† | |||||||
≥3 | 9 (10.7%) | 39 (88.6%) | <0.0001 | ||||
<3 | 75 (89.3%) | 5 (11.4%) | |||||
CRP† | |||||||
≥150 | 11 (13.1%) | 3 (6.8%) | <0.0001 | ||||
<150 | 73 (86.9%) | 41 (93.2%) | |||||
CTSI† | |||||||
≥7 | 15 (21.4%) | 31 (70.5%) | <0.02 | ||||
<7 | 69 (78.6%) | 13 (29.5%) | |||||
Number of AFC† | |||||||
≥2 | 14 (16.7%) | 32 (72.7%) | <0.01 | ||||
<2 | 70 (83.3%) | 69 (27.3%) |
†Number of patients with mild/severe scores